The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
InterSol
Platelet Additive 3 · SODIUM CHLORIDE 452 mg/100mL; SODIUM ACETATE 442 mg/100mL; TRISODIUM CITRATE DIHYDRATE 318 mg/100mL; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 305 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL · Solution · Intravenous · Fenwal, Inc.
NDC 00942-9601-12 · 500 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Fenwal International, Inc.United Statesmanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- BN080041
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Platelet Additive 3 (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fenwal, Inc. | SODIUM CHLORIDE 452 mg/100mL; SODIUM ACETATE 442 mg/100mL; TRISODIUM CITRATE DIHYDRATE 318 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 305 mg/100mL | Aug 26, 2026 | Sep 2, 2026 |
| Fenwal, Inc. | SODIUM CHLORIDE 452 mg/100mL; SODIUM ACETATE 442 mg/100mL; TRISODIUM CITRATE DIHYDRATE 318 mg/100mL; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 305 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL | Aug 26, 2026 | Sep 2, 2026 |
| Fenwal, Inc. | SODIUM CHLORIDE 452 mg/100mL; SODIUM ACETATE 442 mg/100mL; TRISODIUM CITRATE DIHYDRATE 318 mg/100mL; SODIUM PHOSPHATE, DIBASIC 305 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL | Aug 26, 2026 | Sep 2, 2026 |
| Fenwal, Inc. | SODIUM CHLORIDE 442 mg/100mL; SODIUM ACETATE 452 mg/100mL; TRISODIUM CITRATE DIHYDRATE 305 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 318 mg/100mL | Jul 22, 2026 | Aug 19, 2026 |
| Fenwal, Inc. | SODIUM CHLORIDE 442 mg/100mL; SODIUM ACETATE 452 mg/100mL; TRISODIUM CITRATE DIHYDRATE 305 mg/100mL; SODIUM PHOSPHATE, DIBASIC 93 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 318 mg/100mL | Jul 22, 2026 | Aug 19, 2026 |
| Fenwal, Inc. | SODIUM CHLORIDE 442 mg/100mL; SODIUM ACETATE 452 mg/100mL; TRISODIUM CITRATE DIHYDRATE 305 mg/100mL; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 93 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 318 mg/100mL | Jul 22, 2026 | Aug 19, 2026 |
| Fenwal, Inc. | SODIUM ACETATE 442 mg/100mL; SODIUM CHLORIDE 452 mg/100mL; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 305 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL; TRISODIUM CITRATE DIHYDRATE 318 mg/100mL | Jul 15, 2026 | Jul 18, 2026 |
| Fenwal, Inc. | SODIUM ACETATE 442 mg/100mL; SODIUM CHLORIDE 452 mg/100mL; SODIUM PHOSPHATE, DIBASIC 305 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL; TRISODIUM CITRATE DIHYDRATE 318 mg/100mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "InterSol — NDC 00942-9601-12," retrieved September 3, 2026, https://drugdashboards.com/drug/00942960112.
Free to cite with attribution — see how the data is put together.